Skip to main content
. 2020 Feb 4;11:11. doi: 10.1186/s13244-019-0824-5

Table 1.

Gadolinium content in the blood, cerebrum, cerebellum, liver, kidney, skin, and femur (mean values ± SD)

Group (ID) Blood (nmol/mL) Cerebrum (nmol/g) Cerebellum (nmol/g) Liver (nmol/g) Kidney (right) (nmol/g) Skin (nmol/g) Femur (nmol/g)
Control (A) < LOQ < LOQ < LOQ < LOQ < LOQ < LOQ < LOQ
ProHance (B) < LOQa 0.144 ± 0.015b 0.151 ± 0.039 0.361 ± 0.106 38.6 ± 25.0 0.400 ± 0.112 8.48 ± 1.87
Dotarem (C) < LOQ 0.342 ± 0.045°°° 0.315 ± 0.040°°° 0.685 ± 0.330°°° 172 ± 134°°° 0.660 ± 0.202°°° 6.28 ± 3.08
Clariscan (D) < LOQ 0.377 ± 0.042°°,* 0.345 ± 0.053°°° 0.823 ± 0.495°°° 212 ± 121°°° 0.688 ± 0.215°°° 9.44 ± 4.01
Gadovist (E) < LOQ 0.292 ± 0.047°°°,**,### 0.316 ± 0.040°°° 1.22 ± 0.664°°°,**,# 294 ± 127°°°,* 0.999 ± 0.442°°°,**,# 16.1 ± 4.51°°°,***,###

n = 5 for control animals; n = 15 for all other groups except “Dotarem, skin” and “Gadovist, right kidney” where n = 14

Significance vs. group B (ProHance): °°p ≤ 0.01, °°°p ≤ 0.005; vs. group C (Dotarem): *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.005; vs. group D (Clariscan): #p ≤ 0.05, ###p ≤ 0.005

a1 out of 15 values > LOQ (0.165)

b7 out of 15 values < LOQ